A clinical study to evaluate the feasibility and dose delivery accuracy of Volumetric-modulated Dynamic WaveArc therapy
Not Applicable
- Conditions
- Prostate cancer, brain tumor (skull-based tumor)
- Registration Number
- JPRN-UMIN000023870
- Lead Sponsor
- Kyoto University
- Brief Summary
15 cases were registered. DWA treatment was completed in all cases. No grade 2 or higher adverse event was observed. Physical quality assuarances revealed that radiation was very accurately delivered in all the cases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) With severe coexisting diseases such as collagen disease, heart disease, respiratory disease and liver disease. 2) Psychotic disease 3) History of irradiation to the area where VMDWAT is considered to be delivered 4) Dose distribution of VMDWAT is inferior to that of conventional radiotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ratio of the patients who completed the treatment course
- Secondary Outcome Measures
Name Time Method Incidence of acute adverse events, Incidence of severe acute adverse events